Disposition of 7500 shares by Margaret McGlynn of Amicus Therapeutics at 2.8 subject to Rule 16b-3
| NVV1 Stock | EUR 8.68 0.24 2.69% |
Roughly 61% of Novavax's investor base is looking to short. The analysis of current outlook of investing in Novavax suggests that many traders are alarmed regarding Novavax's prospects. The current market sentiment, together with Novavax's historical and current headlines, can help investors time the market. In addition, many technical investors use Novavax stock news signals to limit their universe of possible portfolio assets.
Novavax stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Novavax daily returns and investor perception about the current price of Novavax as well as its diversification or hedging effects on your existing portfolios.
Novavax |
Filed transaction by Amicus Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Novavax Fundamental Analysis
We analyze Novavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Novavax is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Novavax Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novavax stock to make a market-neutral strategy. Peer analysis of Novavax could also be used in its relative valuation, which is a method of valuing Novavax by comparing valuation metrics with similar companies.
Peers
Novavax Related Equities
| 2DG | SIVERS SEMICONDUCTORS | 13.64 | ||||
| 3RKU | RYOHIN UNSPADR1 | 0.94 | ||||
| 0QF | Moderna | 0.83 | ||||
| 8SP | Superior Plus | 2.36 | ||||
| TM9 | NorAm Drilling | 2.45 | ||||
| NOH1 | Norsk Hydro | 2.49 | ||||
| RS6 | Reliance Steel | 3.62 |
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |